OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma
Yuanbo Cui, Chunyan Zhang, Shanshan Ma, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 112
Yuanbo Cui, Chunyan Zhang, Shanshan Ma, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 112
Showing 1-25 of 112 citing articles:
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 122
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 122
The role of m6A methylation in therapy resistance in cancer
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 90
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 90
m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56
Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins
Jingyu Liao, Yi Wei, Junnan Liang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 58
Jingyu Liao, Yi Wei, Junnan Liang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 58
m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer
Zihao Feng, Yanping Liang, Junjie Cen, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 52
Zihao Feng, Yanping Liang, Junjie Cen, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 52
An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma
Dongqi Shao, Yu Li, Junyong Wu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 50
Dongqi Shao, Yu Li, Junyong Wu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 50
Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases
Ya-Zhen You, Yun-Dong Fu, Ming-Jie Huang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5815-5815
Open Access | Times Cited: 49
Ya-Zhen You, Yun-Dong Fu, Ming-Jie Huang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5815-5815
Open Access | Times Cited: 49
The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 39
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 39
FGFR families: biological functions and therapeutic interventions in tumors
Qing Liu, Jiyu Huang, Weiwei Yan, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 36
Qing Liu, Jiyu Huang, Weiwei Yan, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 36
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 11
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 11
N6-Methylandenosine-related lncRNAs as potential biomarkers for predicting prognosis and the immunotherapy response in pancreatic cancer
Zhihui Bai, Qianlin Xia, Wanli Xu, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access | Times Cited: 1
Zhihui Bai, Qianlin Xia, Wanli Xu, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access | Times Cited: 1
Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health
Peipei Li, Yumeng Lin, Hongyun Ma, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Peipei Li, Yumeng Lin, Hongyun Ma, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications
Penghui Li, Xiangjie Fang, Di Huang
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Penghui Li, Xiangjie Fang, Di Huang
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 30
PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism
Guangcong Zhang, Xiang‐Nan Yu, Hongying Guo, et al.
Cancer Research (2023) Vol. 83, Iss. 4, pp. 521-537
Open Access | Times Cited: 19
Guangcong Zhang, Xiang‐Nan Yu, Hongying Guo, et al.
Cancer Research (2023) Vol. 83, Iss. 4, pp. 521-537
Open Access | Times Cited: 19
The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer
Yanan Zhu, Jing Li, Hang Yang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Yanan Zhu, Jing Li, Hang Yang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
FTO-stabilized miR-139–5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway
Baihetiya Azhati, Aerziguli Reheman, Diliyaer Dilixiati, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 741, pp. 109604-109604
Closed Access | Times Cited: 18
Baihetiya Azhati, Aerziguli Reheman, Diliyaer Dilixiati, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 741, pp. 109604-109604
Closed Access | Times Cited: 18
ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages
Xin Hua, Qiuli Xu, Ranpu Wu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Xin Hua, Qiuli Xu, Ranpu Wu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
Xuan Han, Yu Zhu, Juan Ke, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Xuan Han, Yu Zhu, Juan Ke, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Insights into the m6A demethylases FTO and ALKBH5 : structural, biological function, and inhibitor development
Zewei Gao, Xuan Zha, Min Li, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Zewei Gao, Xuan Zha, Min Li, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
FTO Inhibits Epithelial Ovarian Cancer Progression by Destabilising SNAI1 mRNA through IGF2BP2
Meige Sun, Xiaocui Zhang, Fangfang Bi, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5218-5218
Open Access | Times Cited: 27
Meige Sun, Xiaocui Zhang, Fangfang Bi, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5218-5218
Open Access | Times Cited: 27
METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma
Fangfang Ge, Zhenyu Li, Jiaru Hu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Fangfang Ge, Zhenyu Li, Jiaru Hu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer
Bo Qin, Qian Bai, Dan Yan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1995-2003
Open Access | Times Cited: 23
Bo Qin, Qian Bai, Dan Yan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1995-2003
Open Access | Times Cited: 23
Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation
Ruirui Kou, Tian Li, Caizhu Fu, et al.
Environmental Research (2023) Vol. 244, pp. 117783-117783
Closed Access | Times Cited: 16
Ruirui Kou, Tian Li, Caizhu Fu, et al.
Environmental Research (2023) Vol. 244, pp. 117783-117783
Closed Access | Times Cited: 16
Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications
Jinxin Tang, Jinhui Zhang, Lu Yu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Jinxin Tang, Jinhui Zhang, Lu Yu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
